Trial Profile
Measuring Inflammation Cells (CD163 and CD206) With the Purpose of Examining Reduction of Fibrosis in the Liver of Chronic Hepatitis C Patients Following Treatment With the Medication Sofosbuvir
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary)
- Indications Hepatitis C; Liver cirrhosis
- Focus Pharmacodynamics
- 06 Apr 2020 Status changed from active, no longer recruiting to completed.
- 01 May 2018 Status changed from recruiting to active, no longer recruiting.
- 23 Aug 2015 New trial record